so many guys now so fanatically obssessed with sheer vaccination rate
but point is, you need to look more at the actual covid daily infection rate, which is a more accurate indicator of how a country's covid issue is being managed
australia for example has only a 55% vaccination rate, but their covid daily infection rate is 15 times lower than malaysia
Posted by Benhobenhobenho > Oct 3, 2021 2:13 PM | Report Abuse
http://www.financetwitter.com/2021/10/merck-unveils-first-covid-pill-c... Therefore, the molnupiravir pill is not a vaccine, let alone the Holy Grail in fixing the pandemic. It is an oral antiviral, another tool or weapon to fight Covid-19. Vaccinations through jabs are still required to prevent from getting the virus in the first place. The pill provides a good tool for people who refuse to receive vaccine, but ready to take the oral antiviral during the early days of symptom
Tomorrow selling pressure continues for all glove stocks due to breakthrough news of Merck Covid-19 pills and strong rally of recovery stocks in US markets last Friday
Ryan83 Tomorrow selling pressure continues for all glove stocks due to breakthrough news of Merck Covid-19 pills and strong rally of recovery stocks in US markets last Friday 03/10/2021 4:28 PM --------------------------------------------- Start from tomorrow : Gaming, hotels and airlines : Up Vaccines: Down Consumer: Up Gloves: Neutral
Come back again to check end of the week whose predictions more accurate, OK? LOL
Like it or not, Glove companies are the few sectors making handsome profits where others are losing big time! In corporate, it is all about cashflows and let's see how many companies will go bust in 2021.
Thanks pjseow, likely the most accurate and realistic profit projection for FY23 and FY24. Can dump all the "lie-censed" analysts projections in the bin.
genuine_investor Like it or not, Glove companies are the few sectors making handsome profits where others are losing big time! In corporate, it is all about cashflows and let's see how many companies will go bust in 2021.
It won't go bust so soon simply bcos banks don't want to take into account of bad debt! Worst is it might impact the financial performance of those lenders. Let it hang on as long as possible!
Intco/Bluesail each expanding to 130Bil/75Bil capacity (orig capacity 5Bil each)
2 china company combined producing 200Bil (prepandemic 10Bil)..china used to be less than 5% global supply - now becoming 40% of 2022 global supply 500Bil
Reality is China still import gloves from Malaysia. Go and check it out. China will not be a threat to Malaysia gloves industry, pls do your homework lah.
iamnotinvestor , The ASP of US 28 is a consensus between the IB s. Harta CEO gave ASPs between US 30 to 35 of Nitrile gloves for normalised situation while IB s gave ASP numbers between 26 and 30 for normalised state. MARGMA gave a projection of 40 to 60 % higher than pre pandemic ASP. I just take the middle of US 28 for blended based on 75 to 25.Nitrile ratio in.FY 2023. In my personal opinion, the blended.ASP for supermx is between.US 30 and 33.during.normalised state. Anyway ,.ASP.of 28.is still 40 %.higher than pre pandemic of US 19.6 and the nett margin is 25.% which is much higher than the margin of only 8.5 % when the blended ASP was only 19.6 in FY 2019. It can be proven mathematically.a 40 % increase in.ASP can result in tripling of nett margin. With the doubling of capacity, increase in.ASP and margin, you can.see a 7 to 8 x.increase in.PAT.compared with.pre pandemic.earning of 124 millions. This itself has a CAGR of more than 65 % from FY 2019 to 2023. A PE of 15 will give a price of 7 to 8 x of prepandemic price of 70 sen per share not to mention the huge cash in hand of about rm 1 per.share in the company assuming after paying a lucrative 60 s for FY 2022.
---------------------- iamnotinvestor ASP OF 28 for year 2023 n 2024 is way too conservative. I would like to believe at least 40usd. 03/10/2021 5:57 PM
ASP : 28 capacity: 48 billions p.a Revenue : 28 x 48 x 0.8 x 4.15 = 4462 m Nett margin : 25.% PAT : 4462 x 0.25 = 1116 m EPS = 1116/2720 = 41 sen Nitrile to Latex ratio : 80 to 20 % --------------------------------------------------
The post pandemic price based on normalised PE 12 = RM 4.90 should be the fair price. Even if u base on profit margin of 0.2, it would still be ard RM 4.0, being the fair price for post pandemic.
pjseow, given the inflation n hike of raw matls, would you think the ASP will remain low 30 or high 20? I wish it is below 30 or even 20 just to wiped out all the small n up coming competitors. Its OK for Top4 to run at a lost of 100mil per qtr for the upcoming 3 years. They have the cash to burn but how about others? Well I keep it short that glove industry still growing n profit will keep pouring in as long as the Co is well managed. Bottom line stay invested.
The cost of operating expenses of Intco Medical, China and Supermax is about the same now. In the worst situation if cost exceed sales they may just cut production or just let those smaller producers die naturally and eventually ASP will be back to normal or gradually increase. I don't think there is much to worry about the big4.
China gloves may be cheap but normally sold to developing n third world countries like Africa, Asia n South America. Developed countries prefer quality gloves from malaysia
Anyway no use guessing too much about china..most glovers alrdy 50%++ loss prob too late to do anything..have to ride to the end & pray got sharks goreng along the way
iamnotinvestor, as I said earlier , I believe the supermx " BLENDED " ASP will be higher than US30 . My ""Blended "" ASP is not the typical Weighted Mfg ASP of Nitrile and Latexx ASP only but the Blended Mfg.ASP and Distributor ASP. I felt that IB s had neglected the change of supermx OBM business model since March 2020. I will explain it later when.I have time.
---------------------
iamnotinvestor pjseow, given the inflation n hike of raw matls, would you think the ASP will remain low 30 or high 20? I wish it is below 30 or even 20 just to wiped out all the small n up coming competitors
How is glove demand ever going to go back to pre-pandemic level, when pandemic is quite obviously still raging & rampaging with newer & robuster covid variants still emerging all the time
that is just so obviously shorting cartel bullkrapping fearmongering
Benhobenhobenho China gloves may be cheap but normally sold to developing n third world countries like Africa, Asia n South America. Developed countries prefer quality gloves from malaysia 03/10/2021 9:46 PM ------------------------------------------------------ I am quite doubtful about this. Mind check again? It may be true for small gloves makers in China but not the big one example Intco Medical.
high vaxxing rate alone not gonna bring covid under control, vaxxing needs to be combined & integrated with restrictions, good healthcare preventive measures & precautions, use of ppe, tight sop etc.
even highly vaxxed singapore struggling hard to manage covid now
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
FortuneBlooming
4,099 posts
Posted by FortuneBlooming > 2021-10-03 13:53 | Report Abuse
msia kabinet gagal #2 can do voodoo magic & bring down daily infection rate sustainably while completely opening up & loosening up geh
just simply with high vaccination rate only geh, without needing to keep restrictions & tight sop geh